FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Author/sZhao, Gang; Wei, Kevin; Nguyen, Duyen; Lim, Hye-Lim; Rege, Bhagwant; Lu, Dongmei; Zhang, Qi
Date:10/22/2024
Meeting Name:2024 American Association of Pharmaceutical Scientists PharmSci360
State:UT
City:Salt Lake City